Manager TitleAgeSince
Chief Executive Officer - 13/08/2014
Chief Tech/Sci/R&D Officer - 01/03/2021
Director TitleAgeSince
Director/Board Member - 13/08/2014
Chairman - 01/09/2018
Director/Board Member 42 22/07/2019
Change 5-day change 1-year change 3-year change Capi.($)
-7.69%-7.69% - - 3.02M
+0.26%-3.69%+45.63%+129.38% 1,216B
+0.35%-0.34%+45.62%+79.48% 656B
+0.50%-2.13%+31.75%+104.39% 509B
-1.54%-4.61%+45.10%+62.26% 384B
+0.09%-1.82%+71.14%+40.70% 362B
-1.07%-0.97%+29.98%+57.26% 311B
-1.06%-0.92%+7.78%+34.60% 293B
+0.52%-1.26%+45.80%+68.65% 249B
+0.45%-1.76%+35.88%+106.66% 208B
Average -0.96%+0.60%+39.85%+75.93% 465.31B
Weighted average by Cap. -0.08%+0.03%+41.81%+87.97%
Logo BOD Australia
Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.
Employees
-